Inicio / Gastroenterología / Abstracts de gastroenterología / Cognitive behavioural therapy…

Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

0 / 5 (0 votos)
Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 3 September

DOI: https://doi.org/10.1016/S2468-1253(19)30243-2

Autores: Prof Hazel A Everitt, PhD., Prof Sabine Landau, PhD., Gilly O’Reilly, PhD., Alice Sibelli, PhD., Stephanie Hughes, MSc., Sula Windgassen, PhD
et al.

Background: Irritable bowel syndrome (IBS) is common, affecting 10–20% of the adult population worldwide, with many people reporting ongoing symptoms despite first-line therapies. Cognitive behavioural therapy (CBT) is recommended in guidelines for refractory IBS but there is insufficient access to CBT for IBS and uncertainty about whether benefits last in the longer term.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.